ABUS

Arbutus Biopharma Corporation is a biopharmaceutical company dedicated to developing innovative therapies for chronic hepatitis B virus (HBV) infection, with its headquarters located in Warminster, Pennsylvania. Utilizing its proprietary drug development platform, Arbutus is focused on discovering and commercializing novel treatments that target the significant unmet medical needs of HBV patients. The company boasts a promising pipeline of candidates and maintains a commitment to scientific rigor, positioning itself as a key player in the hepatology sector and offering potential for substantial impact in improving patient outcomes.